Hq Spclt Pharma patents expiration
1. Calcium Gluconate In Sodium Chloride patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10342813 | HQ SPCLT PHARMA | Calcium gluconate solutions in flexible containers |
Jul, 2037
(13 years from now) | |
| US10130646 | HQ SPCLT PHARMA | Calcium gluconate solutions in flexible containers |
Jul, 2037
(13 years from now) | |
Drugs and Companies using CALCIUM GLUCONATE ingredient
Market Authorisation Date: 29 October, 2018
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
CALCIUM GLUCONATE IN SODIUM CHLORIDE family patents
2. Dexmedetomidine Hydrochloride patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9649296 | HQ SPCLT PHARMA | Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container |
Apr, 2036
(12 years from now) | |
| US9717796 | HQ SPCLT PHARMA | Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container |
Apr, 2036
(12 years from now) | |
Drugs and Companies using DEXMEDETOMIDINE HYDROCHLORIDE ingredient
Market Authorisation Date: 21 October, 2015
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
DEXMEDETOMIDINE HYDROCHLORIDE family patents
3. Esmolol Hydrochloride Double Strength In Plastic Container patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8835505 | HQ SPCLT PHARMA | Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container |
Mar, 2033
(9 years from now) | |
| US8829054 | HQ SPCLT PHARMA | Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container |
Mar, 2033
(9 years from now) | |
Drugs and Companies using ESMOLOL HYDROCHLORIDE ingredient
Market Authorisation Date: 07 April, 2016
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic